CK Life Sciences Int'l., (Holdings) Inc.

Equities

775

KYG2176J1058

Food Processing

Market Closed - Hong Kong S.E. 04:08:03 2024-03-28 am EDT 5-day change 1st Jan Change
0.335 HKD -2.90% Intraday chart for CK Life Sciences Int'l., (Holdings) Inc. -16.25% -45.97%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
CK Life Sciences Int'l., Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
XtalPi and CK Life Sciences Ink Agreement to Develop Cancer Molecular Diagnostic Models Using AI and Biomarker Data CI
CK Life Sciences to Present Preclinical Study of Cancer Vaccines at US Immunotherapy Conference MT
Ck Life Sciences Int'l., Inc. Announces Preclinical Data for Its Investigational Dual-Antigen Cancer Vaccines, Co-Targeting Prame and PD-L1 CI
CK Life Sciences International's Profit Slumps 43% in H1; Shares Down 3% MT
CK Life Sciences Int'l., Inc. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
CK Life Sciences Int'l., Inc. Announces Ordinary Final Dividend for the Year Ended 31 December 2022, Payment Date 05 June 2023 CI
CK Life Sciences Int'l., Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
XtalPi Inc. and CK Life Sciences to Collaborate in Ai-Empowered Tumour Vaccine Research and Development, Opening A New Paradigm for Scientific Innovation CI
CK Life Sciences Int'l., Inc. Announces Retirement of Independent Non-Executive Director and Change in Composition of the Remuneration Committee CI
CK Life Sciences' H1 Profit Down 35% MT
CK Life Sciences Int'l., Inc. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
CK Life Sciences Investors Acquire Stake in Pharus for $5.5 Million Each MT
CK Life Sciences Int'l., Inc. Announces Ordinary Final Cash Dividend for the Year Ended 31 December 2021, Payable on 01 June 2022 CI
CK Life Sciences Int'l., Inc. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
CK Life Sciences Int'l., Inc. acquired Gale Road vineyard. CI
CK Hutchison : CK Asset profits rise in H1 RE
CK Life Sciences 'l : Posts Higher Profit, Revenue in H1 MT
Ck Life Sciences Int'l., Holdings Inc. Reports Earnings Results for the Half Year Ended June 30, 2021 CI
CK Life Sciences 'l : ' Profit Slumps 31% in 2020 as Pandemic Hits MT
Ck Life Sciences Int'l., Inc. Recommends Final Dividend for the Year Ended 31 December 2020, Payable on May 31, 2021 CI
Ck Life Sciences Int'l., Holdings Inc. Reports Earnings Results for the Full Year Ended December 31, 2020 CI
Market Chatter: Twenty-Nine Hong Kong-Listed Firms Added to Shenzhen-Hong Kong Trading Link MT
Chong Kin : Hong Kong's CK Group buys first Canadian renewable power project RE
Asian shares' valuations drop in October to make them more attractive RE
Chart CK Life Sciences Int'l., (Holdings) Inc.
More charts
CK Life Sciences Intl (Holdings) Inc is an investment holding company principally engaged in the development and sales of healthcare products. The Company operates through two segments. The Health segment is engaged in the development, production, marketing and sales of healthcare and pharmaceutical products. The healthcare brands under the Company include Lipa, Vitaquest and Sante Naturelle, among others. Its pharmaceutical products include cancer-related pharmaceuticals and painkillers, among others. The Agriculture-related Businesses segment is engaged in the operation of vineyards, as well as the development, production, marketing and sales of agriculture and related products. Its agricultural products include fertilizers and crop protection products, among others.
More about the company